Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs) with central nervous system activity. Its structure supports the creation of bioactive molecules due to the piperazine ring’s ability to enhance solubility and binding affinity. Commonly employed in medicinal chemistry for designing analogs in drug discovery programs targeting neurological disorders and psychiatric conditions. Also utilized in the preparation of fluorinated derivatives to improve metabolic stability and bioavailability in candidate drugs.